Ctexli — Medica

Initial criteria

• Diagnosis established by molecular genetic test demonstrating a pathogenic variant in the CYP27A1 gene OR laboratory test demonstrating elevated serum cholestanol levels
• Medication prescribed by or in consultation with a geneticist, neurologist, ophthalmologist, metabolic specialist who treats patients with CTX, or a specialist who focuses in the treatment of CTX

Approval duration

1 year